Internal Medicine · El Paso, TX
NPI
1306987474
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
14470 Horizon Blvd Ste J
El Paso, TX, 79928
Phone (832) 940-7071
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,255 services
Medicare patients, 2024
117
Average age 67
Drug cost, 2024
$6.3M
39,759 prescriptions
Company payments, 2025
$1,050
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mustafa M Moazam was code 99214 (office e&m - established), 450 times for 104 patients. In total Mustafa M Moazam billed 1,255 services in 27 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 450 | 104 | $81.68 | $37K |
| 99458 E&M - Miscellaneous | Office | 223 | 18 | $29.22 | $6,515 |
| 99457 E&M - Miscellaneous | Office | 148 | 22 | $35.55 | $5,261 |
| 99454 E&M - Miscellaneous | Office | 94 | 13 | $33.10 | $3,111 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 59 | 59 | $123.43 | $7,282 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 57 | 57 | $17.80 | $1,015 |
| 80305 Drug Tests | Office | 49 | 17 | $12.35 | $605 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 46 | 46 | $17.82 | $820 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 16 | $11.38 | $250 |
| 99204 Office E&M - New | Office | 15 | 15 | $80.47 | $1,207 |
By year: 2022 $52K for 883 services; 2023 $78K for 1,404 services; 2024 $67K for 1,255 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 49 | 17 | $12.35 | $605 |
Medicare prescription drug claims, 2024
In 2024, the drug Mustafa M Moazam prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,357 prescriptions and refills. In total Mustafa M Moazam wrote 39,759 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,357 | 6,205 | 727 | $23K |
| Alendronate Sodium Generic | 1,678 | 3,799 | 528 | $12K |
| Metformin Hcl Generic | 1,437 | 3,574 | 417 | $8,130 |
| Lisinopril Generic | 1,386 | 3,577 | 418 | $10K |
| Amlodipine Besylate Generic | 1,336 | 3,316 | 390 | $6,886 |
| Levothyroxine Sodium Generic | 1,095 | 2,712 | 284 | $10K |
| Losartan Potassium Generic | 931 | 2,442 | 275 | $8,004 |
| Gabapentin Generic | 844 | 1,569 | 244 | $13K |
| Tamsulosin Hcl Generic | 775 | 1,856 | 243 | $9,727 |
| Omeprazole Generic | 760 | 1,583 | 219 | $12K |
| Montelukast Sodium Generic | 760 | 1,607 | 226 | $6,083 |
| Farxiga Dapagliflozin Propanediol | 615 | 1,185 | 181 | $643K |
| Jardiance Empagliflozin | 614 | 1,364 | 165 | $771K |
| Omega-3 Acid Ethyl Esters Generic | 585 | 1,323 | 213 | $39K |
| Baclofen Generic | 581 | 783 | 208 | $5,612 |
Brand drugs: 5,547 claims; generic drugs: 33,815 claims; opioid claims: 639.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mustafa M Moazam $1,050 ($1,050 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $215.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $215 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $80.57 |
| Abbott Laboratories ABT | 1 | $75.81 |
| Abbvie Inc. ABBV | 5 | $74.97 |
| Genzyme Corporation SNY | 2 | $61.86 |
| Novo Nordisk Inc NVO | 2 | $44.3 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $32.02 |
| Exact Sciences Corporation EXAS | 1 | $25.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.